Traveka Wealth’s AstraZeneca AZN Stock Holding History

Traveka Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$648K	Sell	3,416 -1	-0%	-$188	0.22%	82
2026 Q1	$674K	Sell	3,417 -32	-0.9%	-$6.17K	0.26%	74
2025 Q4	$634K	Buy	3,449 +29	+0.8%	+$5.09K	0.26%	75
2025 Q3	$525K	Buy	3,420 +737	+27%	+$112K	0.23%	73
2025 Q2	$375K	Sell	2,683 -711	-21%	-$99.6K	0.2%	83
2025 Q1	$499K	Buy	3,394 +534	+19%	+$77.3K	0.28%	65
2024 Q4	$375K	Sell	2,860 -246	-8%	-$34.4K	0.21%	82
2024 Q3	$484K	Buy	3,106 +98	+3%	+$15.8K	0.25%	59
2024 Q2	$469K	Buy	3,008 +422	+16%	+$63.5K	0.23%	56
2024 Q1	$350K	Buy	2,586 +146	+6%	+$19.3K	0.16%	73
2023 Q4	$329K	Buy	+2,440	New	+$317K	0.17%	78

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ISS

Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM

Traveka Wealth's AZN Position: Q2 2026 in Review

Traveka Wealth reduced its AstraZeneca (AZN) stake by 0.03% in Q2 2026, selling an estimated $188 and leaving 3,416 shares worth $648K. The position accounts for 0.22% of the portfolio, ranked #82.

Traveka Wealth first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $674K in Q1 2026. 702 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Traveka Wealth held 3,416 shares of AstraZeneca worth $648K as of Q2 2026.
Traveka Wealth sold 1 AstraZeneca share in Q2 2026, an estimated $188.
AstraZeneca made up 0.22% of Traveka Wealth's portfolio in Q2 2026, its #82 holding.
Traveka Wealth first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
Traveka Wealth's AstraZeneca position peaked at $674K in Q1 2026.
702 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.